105 related articles for article (PubMed ID: 28844707)
1. Are we reproducible in measurement of NET liver metastasis?
Moalla S; Arfi Rouche J; Foulon S; Caramella C; Ternes N; Planchard D; Goere D; Ducreux M; Scoazec JY; Deschamps F; Dromain C; Baudin E
Dig Liver Dis; 2017 Oct; 49(10):1121-1127. PubMed ID: 28844707
[TBL] [Abstract][Full Text] [Related]
2. Measurement variability of liver metastases from neuroendocrine tumors on different magnetic resonance imaging sequences.
Lestra T; Kanagaratnam L; Mulé S; Janvier A; Brixi H; Cadiot G; Dohan A; Hoeffel C
Diagn Interv Imaging; 2018 Feb; 99(2):73-81. PubMed ID: 29339222
[TBL] [Abstract][Full Text] [Related]
3. Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases.
Huh J; Park J; Kim KW; Kim HJ; Lee JS; Lee JH; Jeong YK; Shinagare AB; Ramaiya NH
Korean J Radiol; 2018; 19(6):1066-1076. PubMed ID: 30386138
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of inter-observer variability according to RECIST 1.1 and its influence on response classification in CT measurement of liver metastases.
Bellomi M; De Piano F; Ancona E; Lodigiani AF; Curigliano G; Raimondi S; Preda L
Eur J Radiol; 2017 Oct; 95():96-101. PubMed ID: 28987705
[TBL] [Abstract][Full Text] [Related]
5. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
[TBL] [Abstract][Full Text] [Related]
6. Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?
Lavelle LP; O'Neill AC; McMahon CJ; Cantwell CP; Heffernan EJ; Malone DE; Daly L; Skehan SJ
Clin Radiol; 2016 Sep; 71(9):863-8. PubMed ID: 27345612
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
9. Measurements of Hepatic Metastasis on MR Imaging:: Assessment of Interobserver and Intersequence Variability.
Karademir I; Ward E; Peng Y; Wise L; Buckle C; Kunnavakkam R; Oto A
Acad Radiol; 2016 Feb; 23(2):132-43. PubMed ID: 26548855
[TBL] [Abstract][Full Text] [Related]
10. Assessment of colorectal liver metastases using MRI and CT: impact of observer experience on diagnostic performance and inter-observer reproducibility with histopathological correlation.
Albrecht MH; Wichmann JL; Müller C; Schreckenbach T; Sakthibalan S; Hammerstingl R; Bechstein WO; Zangos S; Ackermann H; Vogl TJ
Eur J Radiol; 2014 Oct; 83(10):1752-8. PubMed ID: 25082480
[TBL] [Abstract][Full Text] [Related]
11. Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET/CT in the detection of neuroendocrine tumors.
Carlbom L; Caballero-Corbalán J; Granberg D; Sörensen J; Eriksson B; Ahlström H
Ups J Med Sci; 2017 Mar; 122(1):43-50. PubMed ID: 27894208
[TBL] [Abstract][Full Text] [Related]
12. [Complete and sustained remission of liver metastases from neuroendocrine tumor with somatostatin analogue therapy].
Raizer G; Igaz P; Pregun I; Dabasi G; Rácz K
Orv Hetil; 2011 Mar; 152(10):407-10. PubMed ID: 21354958
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
14. Semi-automatic software increases CT measurement accuracy but not response classification of colorectal liver metastases after chemotherapy.
van Kessel CS; van Leeuwen MS; Witteveen PO; Kwee TC; Verkooijen HM; van Hillegersberg R
Eur J Radiol; 2012 Oct; 81(10):2543-9. PubMed ID: 22264447
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH
J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Imaging of Neuroendocrine Tumor Hepatic Metastases: Does Hepatobiliary Phase Imaging Improve Lesion Conspicuity and Interobserver Agreement of Lesion Measurements?
Morse B; Jeong D; Thomas K; Diallo D; Strosberg JR
Pancreas; 2017 Oct; 46(9):1219-1224. PubMed ID: 28902795
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
18. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.
Mörk H; Ignee A; Schuessler G; Ott M; Dietrich CF
Scand J Gastroenterol; 2007 May; 42(5):652-62. PubMed ID: 17454888
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
Dörffel Y; Wermke W
Ultraschall Med; 2008 Oct; 29(5):506-14. PubMed ID: 19241507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
